Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Analysis of 4-1BB/TNFRSF9/CD137 by ELISA (CAT#: STEM-MB-1563-LGZ)

Introduction

4-1BB, also known as TNFRSF9 or CD137, is a receptor of the tumor necrosis factor superfamily. The human 4-1BB gene encodes a type I transmembrane protein consisting of 255 amino acids, including 17 amino acid N-terminal signal peptide, 169 amino acid extracellular region, 27 amino acid transmembrane region, and 42 amino acid extracellular region. Recombinant Human Soluble 4-1BB is a 167-amino acid polypeptide (17.7kDa) including cystine-rich TNFr-like extracellular domain of 4-1BB. 4-1BB is mainly expressed on the surface of various T cells, but also in B cells, monocytes and a variety of transformed cell lines. This protein contributes to clonal proliferation, survival and T cell development. It also induces peripheral monocyte proliferation, enhances T cell apoptosis induced by TCR/CD3 activation, and modulates CD28 co-stimulation to promote Th1 cell response. Expression of this protein is induced by lymphocyte activation. The TRAF transfer protein binds to this protein and transduces the signal that activates NF-κB. It is also involved in the development of inflammation in high-fat foodborne metabolic syndrome.




Principle

Enzyme-linked immunosorbent assay (ELISA) is an enzyme-labeled solid phase immunoassay technique. Its basic principle is to bind the antigen (or antibody) to the solid phase carrier, and the antigen (or antibody) and a certain enzyme link to enzyme labeled antigen (or antibody). During detection, the sample to be tested and the enzymic antigen (or antibody) react with the antigen (or antibody) on the solid phase carrier according to certain procedures, and then remove the unreacted part by washing method. After adding the substrate, the substrate is catalyzed by the enzyme on the solid phase carrier to produce colored substances. Through qualitative or quantitative detection of the amount of colored products, the content of the substance to be measured in the sample can be determined.

Applications

Oncology & Cancer, Immunology/Inflammation

Procedure

1. Add standards or samples to each well and incubate.
2. Pour off the liquid in the well, biotinylated antibody working solution and incubate.
3. Add enzyme conjugate working solution and incubate.
4. Add substrate TMB and incubate.
5. Add stop solution and measure OD value.
6. Calculation of results.

Materials

• Sample Type: Serum, plasma, cell culture supernatant and other biological samples
Advertisement